Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.8M Buy
93,823
+7,818
+9% +$1.68M 0.03% 424
2026
Q1
$19M Buy
86,005
+2,515
+3% +$615K 0.03% 410
2025
Q4
$21.2M Buy
83,490
+4,012
+5% +$1.01M 0.04% 378
2025
Q3
$19.7M Buy
79,478
+5,872
+8% +$1.41M 0.04% 383
2025
Q2
$17.7M Sell
73,606
-25,282
-26% -$5.89M 0.04% 394
2025
Q1
$22.4M Buy
98,888
+14,216
+17% +$3.13M 0.05% 323
2024
Q4
$17.4M Buy
84,672
+30,064
+55% +$6.6M 0.05% 345
2024
Q3
$13.2M Buy
54,608
+1,190
+2% +$278K 0.03% 393
2024
Q2
$11.7M Sell
53,418
-5,055
-9% -$1.1M 0.03% 415
2024
Q1
$13.1M Sell
58,473
-23,729
-29% -$5.35M 0.04% 409
2023
Q4
$18.1M Buy
82,202
+35,865
+77% +$7.59M 0.06% 347
2023
Q3
$10.2M Sell
46,337
-25,395
-35% -$5.74M 0.04% 417
2023
Q2
$16.1M Sell
71,732
-78,046
-52% -$15.6M 0.07% 354
2023
Q1
$28.6M Buy
149,778
+32,699
+28% +$6.32M 0.13% 226
2022
Q4
$21.6M Sell
117,079
-1,351
-1% -$238K 0.11% 282
2022
Q3
$19.7M Buy
118,430
+20,682
+21% +$4.21M 0.11% 245
2022
Q2
$20.2M Buy
97,748
+36,822
+60% +$8.3M 0.11% 251
2022
Q1
$14.7M Buy
60,926
+29,992
+97% +$6.95M 0.07% 338
2021
Q4
$7.53M Buy
30,934
+4,713
+18% +$1.08M 0.03% 475
2021
Q3
$5.36M Sell
26,221
-11,528
-31% -$2.47M 0.02% 554
2021
Q2
$7.79M Buy
37,749
+3,053
+9% +$615K 0.03% 460
2021
Q1
$6.61M Sell
34,696
-1,412
-4% -$262K 0.03% 451
2020
Q4
$6.84M Sell
36,108
-4,599
-11% -$858K 0.04% 411
2020
Q3
$7.17M Sell
40,707
-2,479
-6% -$396K 0.04% 367
2020
Q2
$6.63M Sell
43,186
-13,446
-24% -$2.05M 0.04% 370
2020
Q1
$7.93M Buy
56,632
+14,906
+36% +$2.23M 0.06% 295
2019
Q4
$6.36M Buy
41,726
+13,861
+50% +$2.03M 0.04% 397
2019
Q3
$4.03M Buy
+27,865
New +$4.16M 0.03% 484

Other funds holding STE

Aviva's STE Position: Q2 2026 in Review

Aviva increased its Steris (STE) stake by 9.1% in Q2 2026, buying an estimated $1.68M and bringing the position to 93,823 shares worth $19.8M. The position accounts for 0.03% of the portfolio, ranked #424.

Aviva first reported a position in STE in Q3 2019 and has held it in 28 quarters since. The position peaked at $28.6M in Q1 2023. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Aviva held 93,823 shares of Steris worth $19.8M as of Q2 2026.
  • Aviva bought 7,818 Steris shares in Q2 2026, an estimated $1.68M.
  • Steris made up 0.03% of Aviva's portfolio in Q2 2026, its #424 holding.
  • Aviva first reported a position in Steris in Q3 2019 and has held it in 28 quarters since.
  • Aviva's Steris position peaked at $28.6M in Q1 2023.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.